Study Summary
This trial will see if taking ketorolac helps pancreatic cancer patients with weight and quality of life.
- Pancreatic Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 13 Secondary · Reporting Duration: 14 days
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Ketorolac (open label)
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Ketorolac Tromethamine · No Placebo Group · Phase < 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many participants are currently engaged in this trial?
"Affirmative. According to clinicaltrials.gov, the recruitment process for this medical trial is still going on and began on July 1st 2022, with a recent update being posted on July 15th of that same year. The team needs 20 individuals at one location to partake in their research." - Anonymous Online Contributor
Are there still available positions for those interested in contributing to this research?
"Currently, the clinical trial is open to recruitment as declared on clinicaltrials.gov; its initial posting was July 1st 2022 and it was last updated two weeks later on July 15th." - Anonymous Online Contributor